Copeland Capital Management’s West Pharmaceutical WST Stock Holding History

Copeland Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-149	Closed	-$31.9K	–	287
2025 Q1	$33.4K	Sell	149 -3,011	-95%	-$830K	﹤0.01%	212
2024 Q4	$1.04M	Sell	3,160 -136	-4%	-$42.8K	0.02%	127
2024 Q3	$989K	Sell	3,296 -91	-3%	-$27.9K	0.02%	132
2024 Q2	$1.12M	Sell	3,387 -112	-3%	-$39.6K	0.02%	128
2024 Q1	$1.38M	Sell	3,499 -82	-2%	-$30.3K	0.03%	122
2023 Q4	$1.26M	Buy	3,581 +226	+7%	+$80K	0.03%	116
2023 Q3	$1.26M	Sell	3,355 -73	-2%	-$28.2K	0.03%	119
2023 Q2	$1.31M	Sell	3,428 -718	-17%	-$256K	0.03%	118
2023 Q1	$1.44M	Sell	4,146 -73	-2%	-$21.3K	0.03%	114
2022 Q4	$993K	Buy	4,219 +3,751	+801%	+$889K	0.03%	125
2022 Q3	$115K	Buy	468 +460	+5,750%	+$140K	﹤0.01%	150
2022 Q2	$2K	Hold	8	–	–	﹤0.01%	267
2022 Q1	$3K	Hold	8	–	–	﹤0.01%	255
2021 Q4	$4K	Sell	8 -5	-38%	-$2.15K	﹤0.01%	232
2021 Q3	$6K	Hold	13	–	–	﹤0.01%	216
2021 Q2	$5K	Hold	13	–	–	﹤0.01%	215
2021 Q1	$4K	Hold	13	–	–	﹤0.01%	222
2020 Q4	$4K	Hold	13	–	–	﹤0.01%	212
2020 Q3	$4K	Hold	13	–	–	﹤0.01%	201
2020 Q2	$3K	Hold	13	–	–	﹤0.01%	202
2020 Q1	$2K	Hold	13	–	–	﹤0.01%	237
2019 Q4	$2K	Hold	13	–	–	﹤0.01%	264
2019 Q3	$2K	Hold	13	–	–	﹤0.01%	260
2019 Q2	$2K	Hold	13	–	–	﹤0.01%	261
2019 Q1	$1K	Hold	13	–	–	﹤0.01%	261
2018 Q4	$1K	Buy	+13	New	+$1.41K	﹤0.01%	269

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Copeland Capital Management's WST Position: Q2 2025 in Review

Copeland Capital Management sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 149 shares — an estimated $31.9K sold.

Copeland Capital Management first reported a position in WST in Q4 2018 and held it in 26 quarters. The position peaked at $1.44M in Q1 2023. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

Copeland Capital Management reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Copeland Capital Management sold 149 West Pharmaceutical shares in Q2 2025, an estimated $31.9K.
Copeland Capital Management first reported a position in West Pharmaceutical in Q4 2018 and held it in 26 quarters.
Copeland Capital Management's West Pharmaceutical position peaked at $1.44M in Q1 2023.
730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Copeland Capital Management's 13F filing for Q2 2025, filed 21 Jul 2025.